Nam‐Kyong Choi
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions 18
- Ophthalmology top 1%
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes 7
-
- Bone health and osteoporosis research 8
- Internal Medicine top 10%
-
- Vaccine Coverage and Hesitancy 14
-
- SARS-CoV-2 and COVID-19 Research 10
-
- Influenza Virus Research Studies 8
-
- Blood Pressure and Hypertension Studies 8
-
- Pharmacy and Medical Practices 7
- Co-authors
- Byung‐Joo ParkJoongyub LeeKyu Hyung ParkSe Joon WooSang Jun ParkBo Ram YangSangshin ParkJu‐Young Shin
- Journals
- Pharmacoepidemiology and Drug Safety (12 papers)Journal of Korean Medical Science (11 papers)PLoS ONE (10 papers)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Nam‐Kyong Choi
124 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 134
- Toxicology 244
- Ophthalmology 384
- Geriatrics and Gerontology 158
- Orthopedics and Sports Medicine 190
- Internal Medicine 62
Countries citing papers authored by Nam‐Kyong Choi
This map shows the geographic impact of Nam‐Kyong Choi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nam‐Kyong Choi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nam‐Kyong Choi more than expected).
Fields of papers citing papers by Nam‐Kyong Choi
This network shows the impact of papers produced by Nam‐Kyong Choi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nam‐Kyong Choi. The network helps show where Nam‐Kyong Choi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nam‐Kyong Choi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2023 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 1 | |
| 14 | 2021 | 8 | |
| 15 | 2021 | 6 | |
| 16 | 2020 | 14 | |
| 17 | 2015 | 7 | |
| 18 | 2014 | 1 | |
| 19 | Risk of Upper Gastrointestinal Bleeding and Degree of Serotonin Reuptake Inhibitions among Elderly Patients in Korea | 2009 | 1 |
| 20 | Adverse Drug Reaction Surveillance and the Role of Family Physicians | 2007 | 2 |
About Nam‐Kyong Choi
Nam‐Kyong Choi is a scholar working on Toxicology, Geriatrics and Gerontology and Health, having authored 135 papers that have together received 2.4k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (18 papers), Vaccine Coverage and Hesitancy (14 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Influenza Virus Research Studies (8 papers), Bone health and osteoporosis research (8 papers), Blood Pressure and Hypertension Studies (8 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Pharmacy and Medical Practices (7 papers). The work is most often cited by research in Toxicology (244 citations), Ophthalmology (384 citations) and Geriatrics and Gerontology (158 citations). Nam‐Kyong Choi has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Byung‐Joo Park, Joongyub Lee, Kyu Hyung Park, Se Joon Woo, Sang Jun Park, Bo Ram Yang, Sangshin Park, Ju‐Young Shin, Yoosoo Chang and Sun‐Young Jung. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Journal of Korean Medical Science, PLoS ONE, Scientific Reports and Osong Public Health and Research Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.